<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02207270</url>
  </required_header>
  <id_info>
    <org_study_id>HSR-14-1479</org_study_id>
    <secondary_id>2033.11</secondary_id>
    <nct_id>NCT02207270</nct_id>
  </id_info>
  <brief_title>Study Of Costs Realized After Percutaneous Coronary intervenTion Employing Same Day Discharge</brief_title>
  <acronym>SOCRATES</acronym>
  <official_title>A Randomized Cost Minimization Analysis Comparing Same Day Discharge With Overnight Hospital Stay Following Elective and Low Risk Urgent Percutaneous Coronary Intervention.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Joseph Mercy Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Michigan Heart, PC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Blue Cross Blue Shield of Michigan Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Saint Joseph Mercy Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the total costs of care associated with
      uncomplicated elective or low-risk urgent percutaneous coronary intervention (PCI) through
      30-day follow up are lower among patients who are randomly assigned to same day discharge
      (SDD) or overnight hospital stay (ON).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized clinical trial of same day discharge versus overnight stay
      for patients undergoing uncomplicated elective or low-risk urgent PCI with uncomplicated
      post-PCI recovery. The outcome is total cost accrued by patients from the time of index
      hospital presentation through 30-day post-PCI follow-up.

      Conduct of PCI procedures and provision of post-PCI care will be in accordance with routine
      institutional practices and will not be protocol-driven.

      Consented patients will be assigned to SDD or ON stay using a block randomization schedule.
      Randomization will occur once the patient has completed an uncomplicated 6-hour post PCI
      observation period.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unable to meet projected enrollment
  </why_stopped>
  <start_date type="Actual">August 11, 2014</start_date>
  <completion_date type="Actual">September 1, 2015</completion_date>
  <primary_completion_date type="Actual">September 1, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized clinical trail</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total costs from a modified societal perspective</measure>
    <time_frame>Index hospital admission to 30-days post-PCI</time_frame>
    <description>Costs will be determined from a modified societal perspective (physician labor, office visit and outpatient drug costs will not be included) and will be reported in 2014 dollars.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total costs from a 3rd party payer perspective</measure>
    <time_frame>Index hospital admission to 30-days post-PCI</time_frame>
    <description>Costs will be determined from a from a 3rd party payer perspective (physician labor, office visit and outpatient drug costs will also be included) and will be reported in 2014 dollars.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse clinical outcomes</measure>
    <time_frame>Index hospital admission to 30-days post-PCI</time_frame>
    <description>Includes death, myocardial infarction, stroke, unplanned cardiac catheterization or coronary revascularization, vascular or hemorrhagic complications.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalization</measure>
    <time_frame>From discharge through 30-day post-PCI</time_frame>
    <description>Inclusive of rehospitalization for any reason.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Same day discharge</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who experienced uncomplicated PCI as well as an uncomplicated 6-hour observation period, will be randomly assigned to same day discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Overnight stay standard care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients who experienced uncomplicated PCI, as well as an uncomplicated 6-hour observation period, will be randomly assigned to an overnight stay, generally considered standard care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Same day discharge</intervention_name>
    <description>Patients randomized to SDD will be discharged home on the day of their PCI, at least 6 hours following its completion. They will receive a follow up phone call from a study coordinator the next day and at 30 days to ascertain what costs (if any) were accrued and whether any adverse outcomes occurred.</description>
    <arm_group_label>Same day discharge</arm_group_label>
    <other_name>SOCRATES</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Overnight Stay</intervention_name>
    <description>Patients who experienced uncomplicated PCI, as well as an uncomplicated 6-hour observation period, will be randomly assigned to an overnight stay, generally considered standard or routine care. Patients randomized to overnight stay will be discharged the following morning to receive a follow up phone call at 30 days to ascertain what costs (if any) were accrued and whether any adverse outcomes occurred.</description>
    <arm_group_label>Overnight stay standard care</arm_group_label>
    <other_name>Standard Care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients who undergo elective or low-risk, (i.e., in the setting of
             unstable angina but not non-ST segment elevation myocardial infarction) urgent PCI.

          -  No sociodemographic factors that would preclude SDD (prohibitive factors include no
             family member/friend available to remain with patient until nurse phone call the
             following day, no working phone, no reliable transportation, home &gt; 60 minutes from
             medical infrastructure, unable to obtain/pay for medications).

          -  PCI procedures performed between 08/04/14 and 08/03/16.

          -  Short term risk of in-hospital death, transfusion or contrast-induced nephropathy
             during the index hospitalization at or below 1% using Blue Cross Blue Shield of
             Michigan Cardiovascular Consortium (BMC2) PCI registry risk prediction models.

          -  No in-lab complications (prolonged angina, acute closure, no reflow, significant or
             untreated dissection, vessel perforation, side branch occlusion, rescue glycoprotein
             IIb/IIIa inhibitor use, ventricular tachycardia or fibrillation requiring
             cardioversion/defibrillation, tamponade, pulmonary edema, stroke or transient ischemic
             attack, shock).

          -  Contrast Volume/Calculated Creatinine Clearance ratio &lt; 3

          -  No recurrent chest pain, shortness of breath, hemodynamic instability, bleeding or
             vascular complications during 6 hours in recovery area post-PCI

        Exclusion Criteria:

          -  Use of rotational atherectomy

          -  Use of a glycoprotein IIb/IIIa inhibitor infusion post-PCI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Herbert D. Aronow, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Michigan Heart, PC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saint Joseph Mercy Health System, St. Joseph Mercy [Hospital] Ann Arbor, Cardiac Catheterization Laboratory</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Jospeh Mercy Health System, St. Joseph Mercy [Hospital] Ann Arbor, Cardiac Catheterization Laboratory</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Abdelaal E, Rao SV, Gilchrist IC, Bernat I, Shroff A, Caputo R, Costerousse O, Pancholy SB, Bertrand OF. Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2013 Feb;6(2):99-112. doi: 10.1016/j.jcin.2012.10.008. Epub 2013 Jan 23. Review.</citation>
    <PMID>23352820</PMID>
  </reference>
  <reference>
    <citation>Amin AP, Marso SP, Rao SV, Messenger J, Chan PS, House J, Kennedy K, Robertus K, Cohen DJ, Mahoney EM. Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding. Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):358-65. doi: 10.1161/CIRCOUTCOMES.110.957290. Epub 2010 May 20.</citation>
    <PMID>20488917</PMID>
  </reference>
  <reference>
    <citation>Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000 Aug 16;284(7):835-42.</citation>
    <PMID>10938172</PMID>
  </reference>
  <reference>
    <citation>Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med. 2000 Dec 15;19(23):3219-36.</citation>
    <PMID>11113956</PMID>
  </reference>
  <reference>
    <citation>Brayton KM, Patel VG, Stave C, de Lemos JA, Kumbhani DJ. Same-day discharge after percutaneous coronary intervention: a meta-analysis. J Am Coll Cardiol. 2013 Jul 23;62(4):275-85. doi: 10.1016/j.jacc.2013.03.051. Epub 2013 Apr 23.</citation>
    <PMID>23623905</PMID>
  </reference>
  <reference>
    <citation>Chambers CE, Dehmer GJ, Cox DA, Harrington RA, Babb JD, Popma JJ, Turco MA, Weiner BH, Tommaso CL; Society for Cardiovascular Angiography and Interventions. Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation. Catheter Cardiovasc Interv. 2009 Jun 1;73(7):847-58. doi: 10.1002/ccd.22100. Review.</citation>
    <PMID>19425053</PMID>
  </reference>
  <reference>
    <citation>Dangas GD, Claessen BE, Mehran R, Xu K, Fahy M, Parise H, Henriques JP, Ohman EM, White HD, Stone GW. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes. JACC Cardiovasc Interv. 2012 Nov;5(11):1097-105. doi: 10.1016/j.jcin.2012.07.012.</citation>
    <PMID>23174632</PMID>
  </reference>
  <reference>
    <citation>Farooq V, van Klaveren D, Steyerberg EW, Meliga E, Vergouwe Y, Chieffo A, Kappetein AP, Colombo A, Holmes DR Jr, Mack M, Feldman T, Morice MC, Ståhle E, Onuma Y, Morel MA, Garcia-Garcia HM, van Es GA, Dawkins KD, Mohr FW, Serruys PW. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet. 2013 Feb 23;381(9867):639-50. doi: 10.1016/S0140-6736(13)60108-7.</citation>
    <PMID>23439103</PMID>
  </reference>
  <reference>
    <citation>Gilchrist IC, Rhodes DA, Zimmerman HE. A single center experience with same-day transradial-PCI patients: a contrast with published guidelines. Catheter Cardiovasc Interv. 2012 Mar 1;79(4):583-7. doi: 10.1002/ccd.23159. Epub 2011 May 13.</citation>
    <PMID>21542123</PMID>
  </reference>
  <reference>
    <citation>Glaser R, Gertz Z, Matthai WH, Wilensky RL, Weiner M, Kolansky D, Hirshfeld J Jr, Herrmann H. Patient satisfaction is comparable to early discharge versus overnight observation after elective percutaneous coronary intervention. J Invasive Cardiol. 2009 Sep;21(9):464-7.</citation>
    <PMID>19726820</PMID>
  </reference>
  <reference>
    <citation>Gurm HS, Dixon SR, Smith DE, Share D, Lalonde T, Greenbaum A, Moscucci M; BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2011 Aug 23;58(9):907-14. doi: 10.1016/j.jacc.2011.05.023.</citation>
    <PMID>21851878</PMID>
  </reference>
  <reference>
    <citation>Gurm HS, Seth M, Kooiman J, Share D. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2013 Jun 4;61(22):2242-8. doi: 10.1016/j.jacc.2013.03.026.</citation>
    <PMID>23721921</PMID>
  </reference>
  <reference>
    <citation>Heyde GS, Koch KT, de Winter RJ, Dijkgraaf MG, Klees MI, Dijksman LM, Piek JJ, Tijssen JG. Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS). Circulation. 2007 May 1;115(17):2299-306. Epub 2007 Apr 9.</citation>
    <PMID>17420341</PMID>
  </reference>
  <reference>
    <citation>Jabara R, Gadesam R, Pendyala L, Chronos N, Crisco LV, King SB, Chen JP. Ambulatory discharge after transradial coronary intervention: Preliminary US single-center experience (Same-day TransRadial Intervention and Discharge Evaluation, the STRIDE Study). Am Heart J. 2008 Dec;156(6):1141-6. doi: 10.1016/j.ahj.2008.07.018. Epub 2008 Oct 9.</citation>
    <PMID>19033010</PMID>
  </reference>
  <reference>
    <citation>Khatri S, Webb JG, Carere RG, Amis A, Woolcott J, Chugh S, Humphries KH. Safety and cost benefit of same-day discharge after percutaneous coronary intervention. Am J Cardiol. 2002 Aug 15;90(4):425-7.</citation>
    <PMID>12161237</PMID>
  </reference>
  <reference>
    <citation>Kim M, Muntner P, Sharma S, Choi JW, Stoler RC, Woodward M, Mann DM, Farkouh ME. Assessing patient-reported outcomes and preferences for same-day discharge after percutaneous coronary intervention: results from a pilot randomized, controlled trial. Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):186-92. doi: 10.1161/CIRCOUTCOMES.111.000069. Epub 2013 Mar 12.</citation>
    <PMID>23481528</PMID>
  </reference>
  <reference>
    <citation>Koch KT, Piek JJ, Prins MH, de Winter RJ, Mulder K, Lie KI, Tijssen JG. Triage of patients for short term observation after elective coronary angioplasty. Heart. 2000 May;83(5):557-63.</citation>
    <PMID>10768908</PMID>
  </reference>
  <reference>
    <citation>Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9.</citation>
    <PMID>15464318</PMID>
  </reference>
  <reference>
    <citation>Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011 Jun 14;123(23):2736-47. doi: 10.1161/CIRCULATIONAHA.110.009449.</citation>
    <PMID>21670242</PMID>
  </reference>
  <reference>
    <citation>Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, Ou FS, Roe MT, Peterson ED, Marso SP; National Cardiovascular Data Registry. Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2009 Jun;2(3):222-9. doi: 10.1161/CIRCINTERVENTIONS.108.846741. Epub 2009 May 8.</citation>
    <PMID>20031719</PMID>
  </reference>
  <reference>
    <citation>Moussa I, Hermann A, Messenger JC, Dehmer GJ, Weaver WD, Rumsfeld JS, Masoudi FA. The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention. Heart. 2013 Mar;99(5):297-303. doi: 10.1136/heartjnl-2012-303379. Epub 2013 Jan 15. Review.</citation>
    <PMID>23322530</PMID>
  </reference>
  <reference>
    <citation>Moscucci M, Rogers EK, Montoye C, Smith DE, Share D, O'Donnell M, Maxwell-Eward A, Meengs WL, De Franco AC, Patel K, McNamara R, McGinnity JG, Jani SM, Khanal S, Eagle KA. Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions. Circulation. 2006 Feb 14;113(6):814-22. Epub 2006 Feb 6.</citation>
    <PMID>16461821</PMID>
  </reference>
  <reference>
    <citation>Patel M, Kim M, Karajgikar R, Kodali V, Kaplish D, Lee P, Moreno P, Krishnan P, Sharma SK, Kini AS. Outcomes of patients discharged the same day following percutaneous coronary intervention. JACC Cardiovasc Interv. 2010 Aug;3(8):851-8. doi: 10.1016/j.jcin.2010.05.010.</citation>
    <PMID>20723858</PMID>
  </reference>
  <reference>
    <citation>Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, Shaw RE, Roe MT, Ho KK, Klein LW, Krone RJ, Weintraub WS, Brindis RG, Rumsfeld JS, Spertus JA; NCDR Registry Participants. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010 May 4;55(18):1923-32. doi: 10.1016/j.jacc.2010.02.005.</citation>
    <PMID>20430263</PMID>
  </reference>
  <reference>
    <citation>Pinto DS, Stone GW, Shi C, Dunn ES, Reynolds MR, York M, Walczak J, Berezin RH, Mehran R, McLaurin BT, Cox DA, Ohman EM, Lincoff AM, Cohen DJ; ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Investigators. Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. J Am Coll Cardiol. 2008 Nov 25;52(22):1758-68. doi: 10.1016/j.jacc.2008.08.021.</citation>
    <PMID>19022155</PMID>
  </reference>
  <reference>
    <citation>Popescu AM, Weintraub WS. Outpatient percutaneous coronary interventions: hospital and health system costs saving while maintaining patient safety. JACC Cardiovasc Interv. 2010 Oct;3(10):1020-1. doi: 10.1016/j.jcin.2010.09.001.</citation>
    <PMID>20965459</PMID>
  </reference>
  <reference>
    <citation>Rao SC, Chhatriwalla AK, Kennedy KF, Decker CJ, Gialde E, Spertus JA, Marso SP. Pre-procedural estimate of individualized bleeding risk impacts physicians' utilization of bivalirudin during percutaneous coronary intervention. J Am Coll Cardiol. 2013 May 7;61(18):1847-52. doi: 10.1016/j.jacc.2013.02.017. Epub 2013 Mar 7.</citation>
    <PMID>23500304</PMID>
  </reference>
  <reference>
    <citation>Rao SV, Kaltenbach LA, Weintraub WS, Roe MT, Brindis RG, Rumsfeld JS, Peterson ED. Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA. 2011 Oct 5;306(13):1461-7. doi: 10.1001/jama.2011.1409.</citation>
    <PMID>21972308</PMID>
  </reference>
  <reference>
    <citation>Rinfret S, Kennedy WA, Lachaine J, Lemay A, Rodés-Cabau J, Cohen DJ, Costerousse O, Bertrand OF. Economic impact of same-day home discharge after uncomplicated transradial percutaneous coronary intervention and bolus-only abciximab regimen. JACC Cardiovasc Interv. 2010 Oct;3(10):1011-9. doi: 10.1016/j.jcin.2010.07.011.</citation>
    <PMID>20965458</PMID>
  </reference>
  <reference>
    <citation>Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, Mehta Z. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005 Jul 2-8;366(9479):29-36.</citation>
    <PMID>15993230</PMID>
  </reference>
  <reference>
    <citation>Waksman R, Barbash IM. The appropriate use of risk scores. JACC Cardiovasc Interv. 2012 Nov;5(11):1106-7. doi: 10.1016/j.jcin.2012.08.007.</citation>
    <PMID>23174633</PMID>
  </reference>
  <reference>
    <citation>Yeh RW, Normand SL, Wolf RE, Jones PG, Ho KK, Cohen DJ, Cutlip DE, Mauri L, Kugelmass AD, Amin AP, Spertus JA. Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention. Circulation. 2011 Oct 4;124(14):1557-64. doi: 10.1161/CIRCULATIONAHA.111.045229. Epub 2011 Sep 6.</citation>
    <PMID>21900079</PMID>
  </reference>
  <reference>
    <citation>Ziakas AA, Klinke BP, Mildenberger CR, Fretz DE, Williams EM, Kinloch FR, Hilton j GJ. Safety of same-day-discharge radial percutaneous coronary intervention: a retrospective study. Am Heart J. 2003 Oct;146(4):699-704.</citation>
    <PMID>14564326</PMID>
  </reference>
  <reference>
    <citation>Ziakas A, Klinke P, Fretz E, Mildenberger R, Williams MB, Siega AD, Kinloch RD, Hilton JD. Same-day discharge is preferred by the majority of the patients undergoing radial PCI. J Invasive Cardiol. 2004 Oct;16(10):562-5.</citation>
    <PMID>15505350</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2014</study_first_submitted>
  <study_first_submitted_qc>July 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2014</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary artery disease</keyword>
  <keyword>Costs</keyword>
  <keyword>Cost minimization</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Risk score</keyword>
  <keyword>Same day discharge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

